Published in Cancer Weekly, November 24th, 1997
The data demonstrate that following a single injection, gene expression was detected for at least six months and potentially indefinitely. These preclinical studies were described in the November 1997 issue of the journal Nature Genetics.
Cell Genesys is the exclusive worldwide licensee of the lentiviral gene delivery technology which was developed at The Salk Institute by Inder Verma, Ph.D. and colleagues. Company scientists,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.